That German company would have already found a solution if a real one existed.
So what is the value of this BBS then:
Real estate. Is it worth checking, even on Google, how “huge” the factory is and considering its value?
The production machines are DIY-made, and I doubt their CE conformity with machine directives, as this company has already had difficulties understanding CE processes. So, hardly any value?
The patents are nearing the end of their protection period. What is their value?
The production manager, CEO, and CFO have already left the company. That tells a lot about the situation.
Who among the shareholders is supposedly going to provide additional funding now? Or do some shareholders have inside information?
BBS has stated that the factory can initially produce 25,000 units per year. In addition, BBS has stated that capacity can be increased to produce hundreds of thousands of units. So, apparently the property is sufficient in size?
Secondly, production machinery.
The factory/quality system has already received CE approval at the end of 2023.
German Connats are draining the last of the money from the coffers. The result is bankruptcy and a big fat zero for shareholders. As mentioned above, even the management has lost faith in this.
@j.salli this is missing more than just product approval. Furthermore, I would be very cautious about the amounts and estimates announced by the company. I don’t mean to be rude, but do you honestly believe the things you’re writing? If an offer had been made for this, everyone would already know about it.
This can almost be bought on payday!
Who’s in to chip in and buy it out?
Then you can always fix your own bones for free when your leg breaks.
But seriously, even if the money is soon enough to buy it, they’ll probably shut down before the end of Q1.
No more money will come from anyone, and buying the patent for over 50,000 euros after such a botched job is a pipe dream. Mostly, someone will buy it as a joke and out of pity (while drunk), if they buy it at all.
CE approval is two-part; product approval and factory/quality system approval.
Factory/quality system approval came in 2023. So the other part is missing from the CE approval; product approval. And yes…it is known that this requires a supplementary clinical trial in humans. The patient count for the first trial was not sufficient according to MDR regulation. But the results were excellent.
There is no need to comment on those other ramblings.
If everything is so simple, shouldn’t this have been sold already? On what do you base the claim that there’s a bidding process going on for this? Why do you feel you are right and others are wrong? I understand that what the “cod” did is unpleasant, but at some point, it’s better to admit to yourself that you were wrong.
Aktiiviomistajat will probably snatch up this carcass too and use it for listing the next company.
A factory cannot receive CE approval. The inspection is carried out by authorities, so it is an official approval.
The quality system is approved by a notified body according to ISO standards, but it is not CE certified.
The factory’s capacity is not the same as the property’s value. The property’s value is what interests us and buyers now.
“”“1. The production machines are DIY-made, and I doubt their CE conformity with the Machinery Directive, as this company has otherwise had difficulties understanding CE processes. So, hardly any value? “””
You yourself wrote the above text and repeatedly used the term CE when commenting on the production machines at the Reisjärvi factory.
To this, I replied by writing that approval has already been obtained in 2023. So, the production machines also meet the requirements.
I apologize, but you seem to have CE matters as unclear as BBS.
Production equipment must be CE marked in accordance with the Machinery Directive. The fact that machines are CE marked does not in any way make the factory CE approved.
In the Reisjärvi newspaper article linked above, the municipal manager says that “To my understanding, the acquisition value of the shares for the municipality has been 2,041,000 euros.”
I somehow thought that the sum would have been larger with all the share issues, given such a large ownership stake. Well, of course, they were no longer involved in the latest issue, and on the other hand, even the brand new municipal manager used the words “to my understanding,” so it sounds a bit uncertain
@j.salli They only interviewed the municipal manager, and otherwise, it didn’t contain any valuable information from an investor’s perspective. It’s great, however, that the local media for the first time woke up to the fact that money has been spent, and it’s also possible that the company won’t become a gold mine.
The municipal manager mainly stated how much money, to his knowledge, had been invested. And apparently, the municipality’s economy won’t collapse even if the rest goes. On the contrary, they were satisfied, as BBS had already employed so many people in the municipality. Reading the article, I also got the impression that the money invested in BBS was supposedly just extra money that was allowed to go, as it had been “won” earlier from the sale of the local electricity company, and it was thus intended to increase the vitality of the municipality. So, in principle, nothing has been lost
They reportedly intend to examine the contents of their securities portfolio more closely later this year and then begin more active management of it.
Let’s hope for a positive resolution to this BBS story, also for Reisjärvi’s sake. It’s a significant employer.
We are eagerly awaiting this primary exit option, what will happen? And when will it happen? What might be the general timeline for these matters handled by ConAlliance?
BBS made the contract with ConAlliance about 2.5 months ago.
@j.salli The CEO of BBS is leaving in about two weeks, and the CFO a week after that. No new individuals have been sought for either role. However, the company is listed, so don’t you see anything strange about this?
Does ConAlliance even want to continue such an agreement when the target company is in this condition? It might be better for their reputation to terminate the agreement and state the fact that they received some invoicing to cover administrative costs, but the success fee was not obtained from this. As stated in the Inderes report: it’s advisable to be cautious and remember the multi-million euro debts the company has.
